Antiallergic activity of H1-receptor antagonists assessed by nasal challenge

The Journal of Allergy and Clinical Immunology

Volumn 82, Issue 5 PART 1, 1988, Pages 881-887

  Bousquet, Jean ^a   Lebel, Bernard ^a   Chanal, Isabelle ^a   Morel, Anne ^a   Michel, François Bernard ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZHYDRYL DERIVATIVE; CYPROHEPTADINE; DRUG DERIVATIVE; HISTAMINE H1 RECEPTOR ANTAGONIST; LORATADINE; PROSTAGLANDIN D2; TERFENADINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HAY FEVER; HISTAMINE RELEASE; HUMAN; IMMUNOLOGY; METHODOLOGY; NOSE PROVOCATION TEST; POLLEN;

ADULT; BENZHYDRYL COMPOUNDS; CYPROHEPTADINE; DOUBLE-BLIND METHOD; HAY FEVER; HISTAMINE H1 ANTAGONISTS; HISTAMINE RELEASE; HUMAN; LORATADINE; NASAL PROVOCATION TESTS; POLLEN; PROSTAGLANDIN D2; TERFENADINE;

EID: 0024110484     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-6749(88)90094-2     Document Type: Article

References (40)

1. Mediator release after nasal airway challenge with allergen
2. Peptide leukotriene release after antigen challenge in patients sensitive to ragweed
3. Inflammatory mediators in the late antigen-induced rhinitis
4. Nasal challenge with cold, dry air results in release of inflammatory mediators: possible mast cell involvement
5. Local generation of sulfidopeptide leukotrienes upon nasal-provocation with cold, dry air
6. Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen
7. Arachidonic acid metabolites during nasal challenge
8. 4 in allergic rhinitis
9. Mediators release in nasal secretions after grass-pollen challenge [Abstract]
10. Correlation between symptoms and release of mediators in secretions during nasal challenge with pollen grains [Abstract]
11. Antiallergic activity of loratadine, a nonsedating antihistamine
12. Bronchodilating activity of mequitazine
13. Intracellular calcium release induced by histamine releasers and its inhibition by some antiallergic drugs
14. Inhibition of acute lung anaphylaxis by aerosolized azelastine in guinea pigs sensitized by three different procedures
15. Evaluation of the CNS properties of SCH 29851, a potential non-sedating antihistamine
16. Batenhorst RL, Batenhorst AS, Graves DA, et al. Pharmacologic evaluation of SCH 29851, chlorpheniramine, and placebo [in press]. Eur J Clin Pharmacol.
17. Suppression of histamine-induced wheal response by loratadine (SCH 29851) over 28 days in man
18. SCH 29851 in the treatment of seasonal allergic rhinitis [Abstract]
19. A comparative study of the efficacy of loratadine (L) and astemizole (A) [Abstract]
20. Clinical studies with terfenadine in seasonal allergic rhinitis in France
21. Antihistaminic effect of terfenadine: a new piperidine-type antihistamine
22. Terfenadine, safety, and tolerance in controlled clinical trials
23. The dry pollen nasal test: its technic, interpretation, and indications
24. Theophylline reduces histamine release during pollen-induced rhinitis
25. Demonstration of inhibition of mediator release from human mast cells by azatadine base: in vivo and in vitro evaluation
26. An in vivo model for the evaluation of topical allergic medications
27. The effect of a topical tricyclic antihistamine on the response of the nasal mucosa to challenge with cold, dry air and histamine
28. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids
29. Skin testing
30. Shelf life of a pollen and a mite standardized extract
31. Inhalation challenge with ragweed pollen in ragweed-sensitive asthmatics
32. Double-blind placebo controlled immunotherapy with fractionated allergoids
33. 2
34. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay
35. Quantitative intranasal pollen challenges. III. The priming effect in allergic rhinitis
36. Evaluation by nasal pollen challenge of immunotherapy with rapidly released ragweed allergens [Abstract]
37. The activity of sodium cromoglycate analogues in human lung in vitro: a comparison with passive cutaneous anaphylaxis and clinical efficacy
38. A double-blind evaluation of skin test suppression produced by two doses of terfenadine
39. 2-agonist, clenbuterol [Abstract]